Pyridinic analog of the natural product (-)-spectaline as potential adjuvant for the treatment of central nervous system disorders

Bioorg Med Chem Lett. 2015;25(10):2247-50. doi: 10.1016/j.bmcl.2015.02.050. Epub 2015 Mar 9.

Abstract

Previously we designed a series of pyridinic anticholinesterasic compounds based on molecular hybridization between tacrine and the natural piperidine alkaloid (-)-3-O-acetylspectaline isolated from Senna spectabilis. Based on the information that the cholinergic system has an important role in the treatment of schizophrenia and depression, we herein report the evaluation of a series of pyridinic compounds in animal models for antipsychotic and antidepressant-like activities. Compound 2 decreased the immobility time of mice in the forced swimming test (5 and 10mg/kg p.o.) and prevented the climbing behavior induced by apomorphine (10mg/kg, p.o.), without impairing animals locomotor activity.

Keywords: Antidepressant-like activity; Antipsychotic; Apomorphine-induced climbing; Forced swimming test; Pyridinic alkaloid analogs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / chemical synthesis
  • Antidepressive Agents / chemistry
  • Antidepressive Agents / pharmacology
  • Behavior, Animal / drug effects
  • Central Nervous System Diseases / drug therapy*
  • Disease Models, Animal
  • Mice
  • Piperidines / chemical synthesis*
  • Piperidines / chemistry
  • Piperidines / pharmacology
  • Piperidines / therapeutic use*
  • Pyridines / chemical synthesis*
  • Pyridines / chemistry
  • Pyridines / pharmacology
  • Schizophrenia / drug therapy

Substances

  • Antidepressive Agents
  • Piperidines
  • Pyridines
  • spectaline